Inkjet Interventions

Can you envisage a future in which deploying a tiny cell-spraying device during vitreoretinal surgery reverses years of retinal cell death? Keith Martin can.

By Mark Hillen

When a man tells you that, in ten years’ time, he envisages treating retinal diseases with a tiny inkjet printer head, you begin to wonder if he’s been drinking strong coffee with too much gusto that morning. But if that man is Keith Martin, Professor of Ophthalmology at the University of Cambridge, you need to revisit that diagnosis.